Developer docs
API playgroundTry for free, no card

Search company profiles

UMAMI Bioworks

Full company profile

uuid0000bvz

Namestring
UMAMI Bioworks
Legal namestring
Umami Bioworks Pte Ltd
Company typeenum
Private
Founded yearint
2020
Descriptiontext

UMAMI Bioworks is a Singapore-based cultivated-seafood biotechnology company, founded in 2020 (originally as Umami Meats, rebranded in 2023) and operating as a private Pte Ltd entity with 11-50 employees. The company targets the production of cell-cultivated seafood from Endangered, Threatened or Protected (ETP) species that are commercially desirable but not farmable, including Japanese Eel, Orange Spotted Grouper, Bluefin Tuna, and Atlantic Cod. Its product surface spans whole-muscle seafood SKUs (fish fillets, fish cakes, fish ball laksa), a pet-food sub-brand (Marina Cat, in partnership with Cult Food Science), and a cell-cultivated supplement line (Marine Radiance, targeting omega fatty acids, collagen, and marine bioactive peptides including GLP-1-adjacent formulations).

The technology stack combines stem-cell biology with a proprietary machine-learning layer. ALKEMYST™ is an ML toolkit using computational biology, machine learning, and digital-twin simulation to accelerate cell line selection, serum-free media development, and process optimization, while the Virtual Marine Cell is a metabolic model that predicts cellular behavior and bioactive outcomes in silico. A plug-and-play automated production architecture is designed for licensing or co-location with seafood producers. The company's go-to-market is B2B and partnership-led: revenue mechanics combine technology licensing (ALKEMYST™), cultivated product supply, and channel distribution through partners such as Maruha Nichiro (Japan's largest seafood company), Nippon Barrier Free (Japan and 18 other countries), IntegriCulture (cosmetics), and Steakholder Foods (3D-printed cultivated seafood). Customer segments include premium restaurants and foodservice, global wellness and supplement brands, cosmetics and personal-care brands, pet food, and seafood producers.

Commercially, UMAMI remains pre-revenue with only USD 2.4 million of disclosed pre-seed equity funding as of March 2022 and active reliance on non-dilutive grants (e.g., Singapore-Israel Industrial R&D grant). Growth capital needs are substantial given the planned USD 10 million Tokyo production facility in 2027, ongoing regulatory pursuit for novel-food approvals in the UK, US, and Singapore, and a recently expanded product portfolio following the March 2024 merger with Shiok Meats.

Short descriptiontext

UMAMI Bioworks is a Singapore-based cultivated-seafood biotechnology company that uses proprietary machine-learning tools (ALKEMYST™ and Virtual Marine Cell) to produce cell-cultivated seafood from endangered or unfarmable species, serving premium foodservice, supplements, cosmetics, and pet-food customers via B2B partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cultivated seafood production, cellular agriculture platform, marine biotechnology solutions, alternative protein manufacturing, cell-cultivated supplements
Industry2 codes
PRIMARYAFANADAL
Aquaculture Harvest, Processing & Packing (Farmed Finfish/Shellfish; On-Farm Plants)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Seafood Processing (Finfish & Shellfish; Wild-Caught & Aquaculture)
SECONDARYCRADADAG
Frozen Seafood Meals & Value-Added Seafood
NAICS code3 codes
  • Seafood Product Preparation and Packaging31171
  • Seafood Product Preparation and Packaging311710
  • Aquaculture1125
SIC code2 codes
  • Prepared Fresh Or Frozen Fish & Seafoods2092
  • Food And Kindred Products2000
Product category
Cultivated Seafood and Cellular Agriculture
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Cultivated Seafood Products
TypeOne Time License
Description

Sale of cultivated seafood products including fish fillets, fish cakes, and other seafood items. Initial market entry in premium restaurants with broader market expansion planned.

umamibioworks.com
2Marine Bioactives and Supplements
TypeOne Time License
Description

Cell-cultivated marine supplement products including omega fatty acids, collagen, and marine bioactive peptides targeting wellness and pharmaceutical applications.

seafoodsource.com
3Technology Licensing and Platform Access
TypeLicensing Royalties
Description

Licensing of ALKEMYST™ platform and production architecture to seafood producers and biotechnology companies.

umamibioworks.com
4Marine Ingredient Distribution
TypeTransaction Fee
Description

Distribution of cultivated marine ingredients for cosmetics and supplements through partnership agreements.

greenqueen.com.hk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Alkemyst
Description

Machine Learning toolkit leveraging computational biology, machine learning, and digital twin technology to accelerate product development process for cultivated seafood

umamibioworks.com
+3 more records
Core offering1 text field

UMAMI Bioworks develops and produces cultivated seafood products from endangered, threatened, or protected (ETP) species such as Japanese Eel, Bluefin Tuna, and Orange Spotted Grouper using a proprietary platform that combines stem cell biology, machine learning (ALKEMYST™), and automated production. The company also produces cell-cultivated marine supplements (Marine Radiance) and pet food (Marina Cat), and licenses its ALKEMYST™ platform and production architecture to seafood producers and biotech firms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Platform can evaluate dozens of feed formulations within hours before physical trials
+1 more record
Product overview1 text field

UMAMI Bioworks is a technology company developing cultivated seafood through a unified platform approach combining ALKEMYST™ (ML-driven development toolkit) and the Virtual Marine Cell (metabolic modeling system). The company produces cultivated seafood from endangered, threatened, or protected species including Japanese Eel, Bluefin Tuna, and Orange Spotted Grouper, alongside new product lines including Marine Radiance (cell-cultivated supplements with omega fatty acids and collagen) and Marina Cat (cultivated fish pet food). The automated production platform enables scalable manufacturing of cultivated seafood products for food, supplements, and cosmetics applications, leveraging partnerships with IntegriCulture for beauty applications and Nippon Barrier Free for distribution in Japan and 18 other countries.

Product and service5 records
1Cultivated Seafood Products
CategoryCultivated seafood
Description

Cell-cultivated seafood products including fish fillets, fish cakes, grouper, and fish ball laksa produced through UMAMI's plug-and-play automated production architecture. Designed for premium restaurant and foodservice markets as a sustainable alternative to wild-caught and overfished species.

2Marine Radiance Cell-Cultivated Supplements
CategoryCell-cultivated supplements
Description

Cell-cultivated marine supplement line providing omega fatty acids, collagen, and marine bioactive peptides without harvesting wild fish. First products include omega fatty acids and peptides designed to work with GLP-1 drugs. Targeted at the global wellness and supplement market and brought to market through partnerships with global wellness brands.

3Marina Cat Cultivated Fish Cat Food
CategoryCultivated pet food
Description

World's first cultivated fish cat food brand developed in partnership with Cult Food Science. Provides a sustainable alternative to traditional fish-based pet food using cultivated seafood technology, targeting the pet food market.

43D-Printed Cultivated Seafood Products
CategoryCultivated seafood
Description

Scalable 3D-printed cultivated seafood products combining 3D printing with cell cultivation technology. Developed in partnership with Steakholder Foods and Singapore's National Additive Manufacturing Innovation Cluster to translate cultivated seafood research into commercial-ready seafood products.

5ALKEMYST Technology Platform (Licensed)
CategoryTechnology licensing and platform
Description

Machine learning toolkit leveraging computational biology, machine learning, and digital twin technology to accelerate cultivated product development. Licensed to seafood producers and biotechnology companies as a standalone technology platform to optimize cell line selection, media development, and process controls.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1Nippon Barrier Free
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-05
Description

Memorandum of Understanding signed for Nippon Barrier Free to serve as sales and distribution partner for cultivated marine cosmetics and supplement ingredients across Japan and 18 other countries. Partnership builds on existing collaboration with IntegriCulture and planned $10M production facility in Japan by 2027.

greenqueen.com.hk
2Shiok Meats
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-03-12
Description

Merger between UMAMI Bioworks and Shiok Meats, two Singaporean cultivated seafood companies. The consolidation aims to accelerate commercialization, leverage combined technologies, improve production efficiency, speed up regulatory approvals, and expand opportunities in the region.

cultivated-x.com
3Maruha Nichiro
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Japan's largest seafood company has partnered with UMAMI Bioworks to bring cultivated seafood to market. Maruha Nichiro provides investment and strategic partnership for commercialization.

umamibioworks.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Two-year R&D collaboration funded by Singapore-Israel Industrial R&D grant to develop scalable 3D-printed cultivated seafood products. Produced portfolio of prototype fish designs combining 3D printing with cell cultivation technology. Companies now partnering with Singapore's National Additive Manufacturing Innovation Cluster.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Tokyo-based biotech startup for beauty and skincare applications. IntegriCulture achieved profitability in 2025 and operates Cellag open brand for cellular agriculture products. Partnership targets marine-derived bioactive ingredients.

6CULT Food Science
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to drive down cultivated seafood industry costs and develop products including Marina Cat, world's first cultivated fish cat food brand.

umamibioworks.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Japan's NUProtein to bring down cost of cultivated seafood through novel protein inputs.

Strategic tierMinorTypeOthers
Description

Research partnership for cell biology and translational research projects.

Strategic tierMinorTypeOthers
Description

Research partnership for cell and molecular biology research.

10Kitasato University
Strategic tierMinorTypeOthers
Description

International research partnership for biotechnology research.

umamibioworks.com
Strategic tierMinorTypeOthers
Description

Research partnership for marine biology and aquaculture research.

Strategic tierMinorTypeOthers
Description

Research partnership for food technology and innovation.

Strategic tierMinorTypeOthers
Description

Research partnership for biotechnology and food science.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based cultivated seafood company focused on cell-cultivated salmon. Directly competes with UMAMI Bioworks on cultivated finfish products for the restaurant and retail channels, with a similar B2B go-to-market motion.

TypeDirect peer
Description

US-based cultivated seafood company producing cell-cultivated yellowtail, sea bream, and mahi-mahi. Competes head-to-head with UMAMI on premium cultivated finfish for foodservice markets.

TypeDirect peer
Description

US-based cultivated seafood company initially focused on bluefin tuna. Directly competes with UMAMI on premium cultivated tuna and adjacent finfish species and on navigating US novel food regulation.

TypeDirect peer
Description

Hong Kong-based cultivated seafood company producing cell-cultivated fish maw and other premium seafood products. Closest APAC peer to UMAMI, sharing the premium Asian seafood positioning and regulatory pathway in Singapore/Hong Kong.

TypeDirect peer
Description

Japan-based cellular agriculture company operating the Cellag platform. Both a UMAMI partner and a direct peer, competing on cultivated meat/seafood technology with a Japan-first commercialization strategy.

TypeDirect peer
Description

Israel-based 3D-printed cultivated meat and seafood company. A UMAMI R&D partner on 3D-printed cultivated seafood products but also a competing technology platform targeting similar B2B applications.

TypeBroad incumbent
Description

US-based cultivated meat company (Good Meat division) with the first commercial cultivated meat approvals. A broader incumbent in cellular agriculture that, while focused on chicken, validates the cultivated meat regulatory and commercialization playbook relevant to UMAMI.

TypeBroad incumbent
Description

US-based cultivated meat company with FDA approval for cultivated chicken. A broader incumbent in cellular agriculture competing for capital, talent, and shelf space that indirectly shapes UMAMI's opportunity.

TypeBroad incumbent
Description

Netherlands-based cultivated meat company using opti-ox technology for pork and beef. A broader incumbent in the cultivated meat space whose technology trajectory and regulatory progress are directly relevant to cultivated seafood economics.

10Maruha Nichiro
TypeOthers
Description

Japan's largest seafood company and a UMAMI flagship partner and investor. Not a competitor but a critical ecosystem participant that supplies distribution, market access, and strategic validation across Japan's seafood value chain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UMAMI Bioworks

Cultivated Seafood and Cellular Agricultureumamibioworks.com

UMAMI Bioworks is a Singapore-based cultivated-seafood biotechnology company that uses proprietary machine-learning tools (ALKEMYST™ and Virtual Marine Cell) to produce cell-cultivated seafood from endangered or unfarmable species, serving premium foodservice, supplements, cosmetics, and pet-food customers via B2B partnerships.

What UMAMI Bioworks does

UMAMI Bioworks is a Singapore-based cultivated-seafood biotechnology company, founded in 2020 (originally as Umami Meats, rebranded in 2023) and operating as a private Pte Ltd entity with 11-50 employees. The company targets the production of cell-cultivated seafood from Endangered, Threatened or Protected (ETP) species that are commercially desirable but not farmable, including Japanese Eel, Orange Spotted Grouper, Bluefin Tuna, and Atlantic Cod. Its product surface spans whole-muscle seafood SKUs (fish fillets, fish cakes, fish ball laksa), a pet-food sub-brand (Marina Cat, in partnership with Cult Food Science), and a cell-cultivated supplement line (Marine Radiance, targeting omega fatty acids, collagen, and marine bioactive peptides including GLP-1-adjacent formulations).

The technology stack combines stem-cell biology with a proprietary machine-learning layer. ALKEMYST™ is an ML toolkit using computational biology, machine learning, and digital-twin simulation to accelerate cell line selection, serum-free media development, and process optimization, while the Virtual Marine Cell is a metabolic model that predicts cellular behavior and bioactive outcomes in silico. A plug-and-play automated production architecture is designed for licensing or co-location with seafood producers. The company's go-to-market is B2B and partnership-led: revenue mechanics combine technology licensing (ALKEMYST™), cultivated product supply, and channel distribution through partners such as Maruha Nichiro (Japan's largest seafood company), Nippon Barrier Free (Japan and 18 other countries), IntegriCulture (cosmetics), and Steakholder Foods (3D-printed cultivated seafood). Customer segments include premium restaurants and foodservice, global wellness and supplement brands, cosmetics and personal-care brands, pet food, and seafood producers.

Commercially, UMAMI remains pre-revenue with only USD 2.4 million of disclosed pre-seed equity funding as of March 2022 and active reliance on non-dilutive grants (e.g., Singapore-Israel Industrial R&D grant). Growth capital needs are substantial given the planned USD 10 million Tokyo production facility in 2027, ongoing regulatory pursuit for novel-food approvals in the UK, US, and Singapore, and a recently expanded product portfolio following the March 2024 merger with Shiok Meats.

UMAMI Bioworks firmographics

Firmographics
Name
UMAMI Bioworks
Legal name
Umami Bioworks Pte Ltd
Website
https://umamibioworks.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
UMAMI Bioworks is a Singapore-based cultivated-seafood biotechnology company that uses proprietary machine-learning tools (ALKEMYST™ and Virtual Marine Cell) to produce cell-cultivated seafood from endangered or unfarmable species, serving premium foodservice, supplements, cosmetics, and pet-food customers via B2B partnerships.
Ownership category
akta.pro rank

UMAMI Bioworks industry classification

Industry
Product category
Cultivated Seafood and Cellular Agriculture
NAICS
Seafood Product Preparation and Packaging (31171), Seafood Product Preparation and Packaging (311710), Aquaculture (1125)
SIC
Prepared Fresh Or Frozen Fish & Seafoods (2092), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFANADAL
Aquaculture Harvest, Processing & Packing (Farmed Finfish/Shellfish; On-Farm Plants)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Seafood Processing (Finfish & Shellfish; Wild-Caught & Aquaculture)
SECONDARYCRADADAG
Frozen Seafood Meals & Value-Added Seafood

Keywords

  • Cultivated seafood production
  • Cellular agriculture platform
  • Marine biotechnology solutions
  • Alternative protein manufacturing
  • Cell-cultivated supplements

Where UMAMI Bioworks is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices1 record

Markets served

UMAMI Bioworks business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Cultivated Seafood Products: Sale of cultivated seafood products including fish fillets, fish cakes, and other seafood items. Initial market entry in premium restaurants with broader market expansion planned.
  2. Marine Bioactives and Supplements: Cell-cultivated marine supplement products including omega fatty acids, collagen, and marine bioactive peptides targeting wellness and pharmaceutical applications.
  3. Technology Licensing and Platform Access: Licensing of ALKEMYST™ platform and production architecture to seafood producers and biotechnology companies.
  4. Marine Ingredient Distribution: Distribution of cultivated marine ingredients for cosmetics and supplements through partnership agreements.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

UMAMI Bioworks product offering

Product offering

Core offering

UMAMI Bioworks develops and produces cultivated seafood products from endangered, threatened, or protected (ETP) species such as Japanese Eel, Bluefin Tuna, and Orange Spotted Grouper using a proprietary platform that combines stem cell biology, machine learning (ALKEMYST™), and automated production. The company also produces cell-cultivated marine supplements (Marine Radiance) and pet food (Marina Cat), and licenses its ALKEMYST™ platform and production architecture to seafood producers and biotech firms.

Product overview

UMAMI Bioworks is a technology company developing cultivated seafood through a unified platform approach combining ALKEMYST™ (ML-driven development toolkit) and the Virtual Marine Cell (metabolic modeling system). The company produces cultivated seafood from endangered, threatened, or protected species including Japanese Eel, Bluefin Tuna, and Orange Spotted Grouper, alongside new product lines including Marine Radiance (cell-cultivated supplements with omega fatty acids and collagen) and Marina Cat (cultivated fish pet food). The automated production platform enables scalable manufacturing of cultivated seafood products for food, supplements, and cosmetics applications, leveraging partnerships with IntegriCulture for beauty applications and Nippon Barrier Free for distribution in Japan and 18 other countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Alkemyst: Machine Learning toolkit leveraging computational biology, machine learning, and digital twin technology to accelerate product development process for cultivated seafood
  • Marine Radiance
  • Virtual Marine Cell
  • Marina Cat

Products and services

  • Cultivated Seafood Products Cell-cultivated seafood products including fish fillets, fish cakes, grouper, and fish ball laksa produced through UMAMI's plug-and-play automated production architecture. Designed for premium restaurant and foodservice markets as a sustainable alternative to wild-caught and overfished species.
  • Marine Radiance Cell-Cultivated Supplements Cell-cultivated marine supplement line providing omega fatty acids, collagen, and marine bioactive peptides without harvesting wild fish. First products include omega fatty acids and peptides designed to work with GLP-1 drugs. Targeted at the global wellness and supplement market and brought to market through partnerships with global wellness brands.
  • Marina Cat Cultivated Fish Cat Food World's first cultivated fish cat food brand developed in partnership with Cult Food Science. Provides a sustainable alternative to traditional fish-based pet food using cultivated seafood technology, targeting the pet food market.
  • 3D-Printed Cultivated Seafood Products Scalable 3D-printed cultivated seafood products combining 3D printing with cell cultivation technology. Developed in partnership with Steakholder Foods and Singapore's National Additive Manufacturing Innovation Cluster to translate cultivated seafood research into commercial-ready seafood products.
  • ALKEMYST Technology Platform (Licensed) Machine learning toolkit leveraging computational biology, machine learning, and digital twin technology to accelerate cultivated product development. Licensed to seafood producers and biotechnology companies as a standalone technology platform to optimize cell line selection, media development, and process controls.

Quantifiable outcome

  • Platform can evaluate dozens of feed formulations within hours before physical trials
  • +1 more outcomes

Companies that use UMAMI Bioworks

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

UMAMI Bioworks technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

UMAMI Bioworks partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core, flagship and minor.

  • Nippon Barrier FreecoreChannel Partner/ Reseller/ Distributor · 5 January 2026Memorandum of Understanding signed for Nippon Barrier Free to serve as sales and distribution partner for cultivated marine cosmetics and supplement ingredients across Japan and 18 other countries. Partnership builds on existing collaboration with IntegriCulture and planned $10M production facility in Japan by 2027.
  • Shiok MeatsflagshipStrategic or Co-development Partner · 12 March 2024Merger between UMAMI Bioworks and Shiok Meats, two Singaporean cultivated seafood companies. The consolidation aims to accelerate commercialization, leverage combined technologies, improve production efficiency, speed up regulatory approvals, and expand opportunities in the region.
  • Maruha NichiroflagshipStrategic or Co-development PartnerJapan's largest seafood company has partnered with UMAMI Bioworks to bring cultivated seafood to market. Maruha Nichiro provides investment and strategic partnership for commercialization.
  • Steakholder FoodscoreStrategic or Co-development PartnerTwo-year R&D collaboration funded by Singapore-Israel Industrial R&D grant to develop scalable 3D-printed cultivated seafood products. Produced portfolio of prototype fish designs combining 3D printing with cell cultivation technology. Companies now partnering with Singapore's National Additive Manufacturing Innovation Cluster.
  • IntegriCulturecoreStrategic or Co-development PartnerCollaboration with Tokyo-based biotech startup for beauty and skincare applications. IntegriCulture achieved profitability in 2025 and operates Cellag open brand for cellular agriculture products. Partnership targets marine-derived bioactive ingredients.
  • CULT Food SciencecoreStrategic or Co-development PartnerPartnership to drive down cultivated seafood industry costs and develop products including Marina Cat, world's first cultivated fish cat food brand.
  • NUProteinminorStrategic or Co-development PartnerPartnership with Japan's NUProtein to bring down cost of cultivated seafood through novel protein inputs.
  • National University of Singapore (NUS)minorOthersResearch partnership for cell biology and translational research projects.
  • Nanyang Technological University (NTU)minorOthersResearch partnership for cell and molecular biology research.
  • Kitasato UniversityminorOthersInternational research partnership for biotechnology research.
  • James Cook UniversityminorOthersResearch partnership for marine biology and aquaculture research.
  • Temasek PolytechnicminorOthersResearch partnership for food technology and innovation.
  • Nanyang PolytechnicminorOthersResearch partnership for biotechnology and food science.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

UMAMI Bioworks competitors and assessment

Company assessment

Direct peers

  • Wildtype: US-based cultivated seafood company focused on cell-cultivated salmon. Directly competes with UMAMI Bioworks on cultivated finfish products for the restaurant and retail channels, with a similar B2B go-to-market motion.
  • BlueNalu: US-based cultivated seafood company producing cell-cultivated yellowtail, sea bream, and mahi-mahi. Competes head-to-head with UMAMI on premium cultivated finfish for foodservice markets.
  • Finless Foods: US-based cultivated seafood company initially focused on bluefin tuna. Directly competes with UMAMI on premium cultivated tuna and adjacent finfish species and on navigating US novel food regulation.
  • Avant Meats: Hong Kong-based cultivated seafood company producing cell-cultivated fish maw and other premium seafood products. Closest APAC peer to UMAMI, sharing the premium Asian seafood positioning and regulatory pathway in Singapore/Hong Kong.
  • IntegriCulture: Japan-based cellular agriculture company operating the Cellag platform. Both a UMAMI partner and a direct peer, competing on cultivated meat/seafood technology with a Japan-first commercialization strategy.
  • Steakholder Foods: Israel-based 3D-printed cultivated meat and seafood company. A UMAMI R&D partner on 3D-printed cultivated seafood products but also a competing technology platform targeting similar B2B applications.

Broad incumbents

  • Eat Just (Good Meat): US-based cultivated meat company (Good Meat division) with the first commercial cultivated meat approvals. A broader incumbent in cellular agriculture that, while focused on chicken, validates the cultivated meat regulatory and commercialization playbook relevant to UMAMI.
  • Upside Foods: US-based cultivated meat company with FDA approval for cultivated chicken. A broader incumbent in cellular agriculture competing for capital, talent, and shelf space that indirectly shapes UMAMI's opportunity.
  • Meatable: Netherlands-based cultivated meat company using opti-ox technology for pork and beef. A broader incumbent in the cultivated meat space whose technology trajectory and regulatory progress are directly relevant to cultivated seafood economics.

Others

  • Maruha Nichiro: Japan's largest seafood company and a UMAMI flagship partner and investor. Not a competitor but a critical ecosystem participant that supplies distribution, market access, and strategic validation across Japan's seafood value chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

UMAMI Bioworks social profiles

Digital presence

UMAMI Bioworks financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UMAMI Bioworks leadership team

Management profile

Number of profiles

Profiles13 records

UMAMI Bioworks funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UMAMI Bioworks M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UMAMI Bioworks

What does UMAMI Bioworks do?

UMAMI Bioworks develops and produces cultivated seafood products from endangered, threatened, or protected (ETP) species such as Japanese Eel, Bluefin Tuna, and Orange Spotted Grouper using a proprietary platform that combines stem cell biology, machine learning (ALKEMYST™), and automated production. The company also produces cell-cultivated marine supplements (Marine Radiance) and pet food (Marina Cat), and licenses its ALKEMYST™ platform and production architecture to seafood producers and biotech firms.

Is UMAMI Bioworks a public or private company?

UMAMI Bioworks is a private company. It is classified as venture growth investor backed and is currently operating.

When was UMAMI Bioworks founded?

UMAMI Bioworks was founded in 2020. It employs 11 to 50 people.

Where is UMAMI Bioworks based?

UMAMI Bioworks is headquartered in Singapore, Singapore, in the Asia region.

How does UMAMI Bioworks make money?

Four revenue lines are on record. Cultivated Seafood Products are the primary driver. The others are marine Bioactives and Supplements, technology Licensing and Platform Access and marine Ingredient Distribution.

Who are UMAMI Bioworks's main competitors?

Direct peers on record are Wildtype, BlueNalu, Finless Foods, Avant Meats, IntegriCulture and Steakholder Foods. Broad incumbents are Eat Just (Good Meat), Upside Foods and Meatable. Maruha Nichiro is listed as an others.

Does UMAMI Bioworks have an API?

No public API is recorded for UMAMI Bioworks.

What industry is UMAMI Bioworks in?

UMAMI Bioworks's product category is Cultivated Seafood and Cellular Agriculture. Its primary akta.pro industry code is AFANADAL, Aquaculture Harvest, Processing & Packing (Farmed Finfish/Shellfish; On-Farm Plants), with a secondary code of CRADADAG, Frozen Seafood Meals & Value-Added Seafood. Its NAICS code is 31171 and its SIC code is 2092.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SeafoodSourcePlant-Based & Cell-BasedSeveral companies involved in plant-based and cell-based seafood and alternative proteins announced developments and partnerships. Notable activities include acquisitions, product launches, funding, and regulatory progress from companies such as BlueNalu, Atlantic Fish, Revo Foods, and Umami Bioworks.SeafoodSourceUMAMI Bioworks bringing cell-cultivated marine supplement line to marketSingapore-based marine alternatives biotechnology company UMAMI Bioworks has announced a new cell-cultivated supplement line called Marine Radiance, providing omega fatty acids, collagen, and marine bioactive peptides without harvesting wild fish. The company aims to address the growing demand for marine-derived nutrition while relieving strain on ocean resources, targeting the USD 704 billion global supplement market. The first products, including omega fatty acids and peptides designed to work with GLP-1 drugs, will be brought to market through partnerships with global wellness brands.Coherent Market InsightsCaviar Market Size, Opportunities, & YoY Growth Rate, 2033The global caviar market is projected to grow from USD 450.0 million in 2026 to USD 771.3 million by 2033, representing a compound annual growth rate of 8.0%, driven by increasing demand for gourmet and luxury food products and rising awareness of caviar's nutritional benefits. Market segmentation shows Sevruga leading by product type (29.5% share), fresh form dominating (35.7%), and restaurants representing the largest application segment (56.8%), while Asia Pacific is expected to lead regionally with 39.2% market share. Key industry developments include Tsar Nicoulai Caviar's acquisition of Sterling Caviar in December 2024, positioning the combined entity as North America's largest sustainable caviar producer, alongside innovations such as UMAMI Bioworks' cultivated lab-grown caviar announced in February 2025.The Fish SiteNew Virtual Marine Cell Platform promises breakthroughs in aquaculture and marine bioactivesUmami Bioworks has launched the world's first Virtual Marine Cell, a constraint-based metabolic model powered by augmented intelligence and machine learning that simulates aquatic species' cellular behaviour with species-specific datasets from tuna, salmon, eel and other high-value organisms. The platform aims to replace years of trial-and-error with predictive insights for aquaculture, cultivated seafood, and marine bioactive discovery. The company is already collaborating with leading global seafood, aquaculture, biotech, and consumer-goods companies to apply the platform to production performance, resilience, and bioactive discovery challenges.SeafoodSourceUmami Bioworks unveils AI advances to its algal oil feed productionSingapore-based biotechnology company Umami Bioworks announced advancements to its AI technology Alkemyst, which creates a Virtual Marine Cell to predict how fish cells metabolize nutrients and algal oils before physical feed trials begin. The technology can evaluate dozens of feed formulations within hours and sends only viable candidates to physical trials, reducing time, costs, and guesswork in feed development. This upgrade aims to address rising feed costs and tightening fish oil supply in aquaculture operations, where feed typically represents the largest single cost.WorldbiomarketinsightsUMAMI Bioworks and Nippon Barrier Free to advance marine-derived ingredientsSingapore-based UMAMI Bioworks has signed a Memorandum of Understanding with Japan's Nippon Barrier Free to collaborate on developing next-generation marine ingredients for cosmetics and supplements markets across Japan and 18 other countries. Under the agreement, Nippon Barrier Free will act as UMAMI Bioworks' sales and distribution partner for marine cell-based ingredients, with their first product being animal-free polydeoxyribonucleotide (PDRN) traditionally derived from salmon sperm. Japan is working on regulatory frameworks for novel foods since late 2024, while UMAMI Bioworks awaits approvals for human consumption in the UK, US, and Singapore.foodnavigator-asia.com5 key APAC food & beverage trends to watch in 2026This article outlines five key food and beverage trends expected to shape the APAC industry in 2026: localisation strategies by multinationals, AI integration in food production and retail, Gen Z-driven product innovation, growth in low-to-no alcohol beverages, and blended/hybrid protein development. Industry executives from companies including Mars Wrigley, Suntory, and Heineken are quoted discussing market strategies, with examples ranging from AI-powered meal vending machines in Singapore to sparkling baijiu launches in China. The piece draws on data from NielsenIQ and features companies like Aikit, Umami Bioworks, and Nourish Ingredients that are developing relevant technologies, positioning 2026 as a pivotal year for industry transformation in the region.GreenqueenUmami Bioworks Deepens Japan Focus with New Distribution PartnershipSingaporean cellular agriculture company Umami Bioworks has signed a Memorandum of Understanding with Nippon Barrier Free to serve as its sales and distribution partner for cultivated marine cosmetics and supplement ingredients across Japan and 18 other countries. The partnership builds on Umami Bioworks' existing collaboration with IntegriCulture and its planned $10M production facility in Japan by 2027, while leveraging its AI platform Alkemyst for cell-based marine ingredient development. The move targets Japan's clean beauty market, projected to grow 16% annually and exceed $1B by 2030.GreenqueenJapanese Biotech Pioneer Launches ‘Open Brand’ to Drive Adoption of Cellular AgricultureTokyo-based IntegriCulture has launched Cellag, an 'open brand' designed to sell cellular agriculture products from itself and other companies across food, cosmetics, and materials categories, aiming to collectively grow the sector into an industry valued by all. The brand launch marks the culmination of a significant year for the company, which has secured a ¥100M loan from Mizuho Bank, commissioned commercial-scale animal-free serum production, and established multiple R&D partnerships including collaborations with Ichimasa Kamaboko, Maruha Nichiro, Umami Bioworks, and Tsunan Sake Brewery. The initiative responds to what IntegriCulture describes as an impending 'protein crisis', with global meat demand projected to grow 6% by 2034 while resources remain insufficient to meet demand sustainably.openPR.comSegmentation, Major Trends, and Competitive Overview of the Cultured Meat MarketThe Business Research Company released a market report projecting the global cultured meat industry will reach $0.54 billion by 2029 with an 18.3% CAGR, driven by cost reductions and consumer demand for sustainable protein. The report highlights key strategic developments such as UPSIDE Foods' acquisition of Cultured Decadence and product innovations like Umami Bioworks' cultivated fish balls. It provides a comprehensive segmentation of the market across product types, applications, distribution channels, and end-users.